China Life’s operating profit jumped 55% to 186.12bn yuan (US$27.31bn) in 2025, while New China Life and Ping An posted gains of 29% and 11%, respectively.
Fitch has identified correlated aggregation risk as the key near-term concern for specialty insurers, even as the agency maintains a broadly contained ratings outlook.